BANGALORE, India, e HYDERABAD, India–(BUSINESS WIRE)–Pandorum Technologies, specialista della medicina rigenerativa in fase clinica impegnato nello sviluppo di una piattaforma di nuova generazione per la rigenerazione programmabile dei tessuti, oggi …
Uncategorized
Resumen: Pandorum Technologies y Nucelion Therapeutics anuncian una colaboración estratégica para elaborar una terapia regenerativa de tejidos con base en exosomas para enfermedades oculares en mercados de APAC
BANGALORE (India) e HYDERABAD (India)–(BUSINESS WIRE)–Pandorum Technologies, una empresa de medicina regenerativa de fase clínica que está diseñando una plataforma de próxima generación para regeneración de tejidos programable, anunció hoy una colabo…
Uncategorized
Alcon Terminates Agreement to Acquire STAAR Surgical
GENEVA–(BUSINESS WIRE)–Alcon Terminates Agreement to Acquire STAAR Surgical
National Vision Announces Participation in the 2026 ICR Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the 2026 ICR Conference on Tuesday, January 13, 2026, at 9:00 a.m. Eastern Time….
Uncategorized
Okyo appoints Robert J. Dempsey as CEO
Okyo Pharma appointed Robert J. Dempsey to serve as the company’s next CEO, according to a press release.Dempsey has more than 20 years of experience in global ophthalmology and has held leadership roles at several companies. As group vice president an…
Uncategorized
SpliceBio nombra a Don Muñoz director financiero
BARCELONA–(BUSINESS WIRE)–SpliceBio, una empresa de medicamentos genéticos en fase clínica pionera en el empalme de proteínas para tratar enfermedades causadas por mutaciones en genes grandes, ha anunciado hoy el nombramiento de Don Muñoz como direct…